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Abstract
Background and aims: In acute pancreatitis (AP), patients with persistent organ failure [POF, duration
of organ failure (OF) 48 h] and transient organ failure (TOF, duration of OF <48 h) have different
outcomes. We have compared the clinical course and outcome of patients with severe AP (SAP) with TOF
and POF in the first week of hospitalization as well as the impact of change in the OF score in the first
week on patient outcome.
Methods: Consecutive patients with SAP were evaluated for OF and its dynamics during the first week
of hospitalization. The modified multiple organ failure score (MOFS) was used to identify OF, grade its
severity and monitor its progression. The clinical course and outcome of patients were studied.
Results: Of 114 patients, mean age 39.2  13.7 years, 37 (32.5%) patients had no OF, 34 (29.8%) had
TOF and 43(37.7%) had POF. Patients with POF had the higher infected necrosis, increased requirement
for percutaneous drain placement, surgery and higher mortality as compared with those with TOF. The
odds ratio for mortality with persistent and deteriorating OF was 26.2 [confidence interval (CI) 5.1–134.9]
compared with only persistent OF.
Conclusion: The dynamics of OF in the first week of SAP predicts the clinical course and outcome.
Persistent and deteriorating OF indicates a poor outcome.
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Introduction
Acute pancreatitis (AP) has a variable clinical course: mild AP has
a very low mortality (less than 1%),1,2 whereas mortality for
severe AP (SAP) can be as high as 10% to 30% depending on the
presence of organ failure (OF) or necrosis.3 AP evolves through
two distinct stages: the first stage is related to the inflammatory
cytokine storm and usually lasts for a week. During this phase, the
severity of AP is related to systemic inflammatory response (SIRS)
elicited by acinar cell injury. About half the deaths occur within
the first week or two, usually as a result of multi-organ failure.4–6
The mortality peak in the second phase is related to OF secondary
to sterile or infected necrosis, or complications from surgical
intervention. After the second week of illness, patients succumb to
pancreatic infection associated with multi-organ failure.7–10 Pre-
dicting the severity of pancreatitis early in the course of disease is
critical to optimize treatment.11 The Atlanta criteria are a widely
used clinically-based classification system for severity of AP which
incorporates OF and local complications.12 However, it does not
differentiate between (i) single and multiple OF, and (ii) grade
(severity) and duration of OF. Multi-organ failure that is persist-
ent should render a patient more susceptible to death.12
The modified multiple organ failure score (MOFS, Modified
Bernard score) is a composite scoring system widely used to
assess multiple organ failure.13 Buter et al. applied MOFS (with
the modification, by excluding hepatic dysfunction; as rise in
bilirubin may be confounding in gall stone pancreatitis) for the
grading and monitoring of organ dysfunction in AP.14 This
scoring system is helpful as a score of 2 can be approximated to
a OF definition using Atlanta criteria. The parameters are specific,
easily obtained and are generally independent of therapy.14
Johnson et al. showed that patients who have OF which persists
for three or more days (persistent organ failure, POF) have a
greater risk of a fatal outcome as compared with patients with OF
that resolves within 48 h (transient organ failure, TOF).15 Buter
et al. described a poor outcome of patients with deteriorating
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organ dysfunction in SAP.14 However, there are no data on OF
which takes into account the dynamics of OF (severity, duration
and progression) in the early phase of SAP, particularly in the first
week of illness. We hypothesized that those patients who have
deterioration of MOFS either as a result of an increase in the
number of organs failing or progressive worsening of OF in the
first week of illness would have a poorer outcome. The aim of this
study was to compare the clinical course and outcome of patients
with TOF and POF in the first week of admission among those
with SAP and to describe the dynamic nature of OF.
Methods
In this prospective observational study conducted in the depart-
ments of Gastroenterology and General Surgery in Postgraduate
Institute of Medical Education and Research, a tertiary care refer-
ral centre at Chandigarh, India, between January 2009 and March
2012, 114 consecutive patients with SAP were included as per the
inclusion and exclusion criteria. Informed consent was taken
from all the patients. The study was approved by the institute’s
ethics board and the Indian Council of Medical Research
(ICMR) guidelines for conducting a research were followed. The
diagnosis of AP was made by (any two of the three); (a) acute
abdominal pain, (b) elevated serum amylase (more than thrice
upper limit of normal range) and (c) typical appearance on
ultrasound (USG) and/or contrast-enhanced computed tomog-
raphy (CECT). SAP was defined by the presence of any of the
following; (i) organ failure,14 (ii) local complications (necrosis,
abscess and pseudocyst), (iii) computed tomography severity
index (CTSI) >7, and (iv) APACHE II score >8. Onset of OF in
the first week of hospitalization was defined as early onset OF
and onset after the first week was considered as late onset OF.
The inclusion criteria were: (i) the presence of SAP, (ii) patients
more than 12 years of age, and (iii) patients presenting within
48 hours of onset of abdominal pain. The exclusion criteria were:
(i) patients with known severe pre-existing co-morbid illness
(chronic kidney disease, cirrhosis, chronic obstructive airway
disease, bronchial asthma and congestive heart failure) and (ii)
patients known to have chronic pancreatitis.
All patients underwent a detailed clinical examination and rel-
evant investigations. CECT abdomen was carried out to grade the
severity of pancreatitis by calculating the Balthazar score and
CTSI after 72 h of onset of pain. The APACHE II score (at 24 h)
and C-reactive protein (CRP) levels (at 48 h) were calculated.
Patients were monitored for the presence and severity of OF (as
per modified organ failure score,MOFS, Table 1) every day during
the first week. Thus, we evaluated renal, pulmonary, cardiovascu-
lar, central nervous and coagulation system failure. Patients with
MOFS of two in any organ systems were recorded as having OF
on that day. Patients with OF lasting for < 48 hours were consid-
ered to have TOF and those with duration of OF lasting for  48
hours were considered to have POF. The MOFS difference (MOFS
on Day 7 minus MOFS on day 1) was calculated as a measure of
dynamic change in severity of OF.
All patients were managed according to standard recommen-
dations16 which included intensive resuscitation, fluid and electro-
lyte monitoring, nutritional support (nasojejunal feeding or total
parenteral nutrition) and supportive care. Infected pancreatic
necrosis (IN) was diagnosed if image-guided fine needle aspira-
tion (considered when persistent fever and/or leucocytosis
was (were) present and after excluding other causes) or the opera-
tive specimen showed isolates on bacterial culture and/or Gram
staining. Patients with symptomatic fluid collection underwent
radiologically-guided percutaneous catheter drainage (PCD)
using a 10-Fr catheter (with upgrading of size when there was
thick residual collection) as per the technique described earlier.17
Surgery in the form of necrosectomy and closed lesser sac drain-
age was offered on evidence of IN not responding to conservative
management, worsening of OF in spite of medical management,
an uncontrolled haemorrhage or local complications. The clinical
course of these patients was followed until the completion of their
hospital stay. Parameters evaluated for the hospital course and
outcome included the occurrence of IN, blood stream infection,
the need for PCD insertion, need for surgery, total hospital stay
and mortality. The hospital course and mortality was compared
between groups with and without OF.
Statistical analysis
The data was analysed using SPSS software (version 17; SPSS Inc.,
Chicago, IL, USA). For normally distributed data, continuous
variables were compared using the Student’s t-test. For more than
two groups one-way anova was used. Quantitative data were
described as a mean and standard deviation with 95% confidence
Table 1 Modified multiple organ failure score14
Score
0 1 2 3 4
Cardiovascular system (SBP, mm of Mercury) >90 <90 <90, fluid nonresponsive <90, pH<7.3>7.2 <90, pH<7.2
Respiratory (FIO2/PO2) >400 301–400 201–300 101–200 <101
Glasgow Coma Scale 15 13–14 10–12 6–9 <6
Platelet count (109/l) >120 81–120 51–80 21–50 <21
Creatinine (mg/dl) <1.5 1.5–1.9 2.0–3.4 3.5–4.9 >4.9
FiO2, fraction of inspired oxygen; PO2 , partial pressure of oxygen; SBP, systolic blood pressure.
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intervals. Categorical data were shown as proportions. A compari-
son of the TOF and POF groups was carried out for various
categorical variables using the chi-square test association to find
out any statistical association between these. Spearman’s correla-
tion coefficients were also calculated between different quantita-
tive variables. Univariate and multivariate analysis were used for
the identification of predictors of mortality.
Results
Demographic data
We enrolled 114 patients with SAP in our study (Table 2) with a
mean age of 39.2  13.7 years, (male to female ratio; 2.1:1).
Alcohol (n = 57, 50.0%) was the most common cause followed
by gall stones (n = 35, 30.7%) and others, 19.3% [8 cases of idio-
pathic pancreatitis, 7 cases of traumatic pancreatitis, 6 cases of
post-endoscopic retrograde cholangiopancreatography pancreati-
tis and 1 case of hyperparathyroidism (and hypercalcemia) asso-
ciated pancreatitis]. The organ systems assessed as per MOFS and
the nature of OF is described in Table 3. As per the MOFS for
defining and grading severity of organ failure, 37 (32.5%) patients
had no OF, whereas 34 (29.1%) had TOF and 43 (37.7%) had POF
(Table 4). Twenty-one patients had 2 organ failures and 16
patients had >2 organ failures.
Markers of disease severity
The markers of disease severity were different between the differ-
ent organ failure groups. The mean APACHE II scores were sig-
nificantly different between the groups (anova P < 0.001) and
between each other on post-hoc analysis. The serum CRP levels
were comparable between the groups (anova P = 0.055) but were
significantly different between the TOF and POF groups (post-
hoc, P = 0.048). There was a significant difference in body mass
index (BMI) between the groups (anova P < 0.001). However,
post-hoc analysis showed no difference between patients with no
OF and those with TOF (P = 0.814). The difference between
patients with no OF compared with POF (P < 0.001) and those
with TOF compared with POF (P = 0.001) were significant. The
radiological markers of severity, Balthazar score (P < 0.001) and
CTSI (P < 0.001) were significantly different between the groups.
Similarly, the MOFS difference was significantly different between
the groups; no OF versus TOF (P = 0.03), no OF versus POF
(P = 0.001) and TOF versus POF (P = 0.001).
Infections during the course of illness
The occurrence of blood stream infections were significantly
higher in patients with POF when compared with those with TOF
(c2 P < 0.001) and similarly an occurrence of IN also followed the
same trend (c2 P = 0.001). The predominant isolate in blood was
Escherichia coli and from infected necrosis it was Enterococcus
species. The antibiotic sensitivity pattern showed that most bacte-
ria were sensitive to quinolones and third generation cepha-
losporins, ceftriaxone and ceftazidime.
Requirement for interventions
Patients with POF had a higher requirement for PCD insertion (c2
P = 0.01) and surgery (c2 P = 0.007) as compared with patients
with TOF. Specific indications for surgery (n = 19) were IN and
multiple organ dysfunction syndrome in 12, failure of conserva-
tive management in 5, pseudoaneurysmal bleed in 1 and emphy-
sematous pancreatitis in 1 patient.
Outcome
ICUadmissionwas required for 2 patients in theTOFgroup and 20
patients in the POF group (c2 P = 0.01). Themean duration of ICU
stay for patients in the POFgroupwas 12.8 5.7 days and 3.2 1.2
days in the TOF group (c2P= 0.004).The total duration of hospital
staywas significantlymore inpatientswithmore severeOF (anova
P = 0.003). Overall mortality was 18.4%. Mortality was 40% for
patients with POF and nil for the TOF group (c2 P < 0.001). The
specific cause of death was MODS in 17 patients, post-operative
bleed in 1, emphysematous pancreatitis in 1 and unrelated in 2
(intracranial haemorrhage and acute myocardial infarction).
Predictors of mortality
Univariate analysis showed APACHE II scores, serum CRP levels,
BMI, CTSI, deterioration of organ failure (MOFS difference), OF
and IN as predictors of mortality. On multivariate analysis, the
MOFS difference [odds ratio (OR) = 7.5; confidence interval (CI)
= 2.3 to 27.3, P = 0.001] APACHE II scores (OR = 12.6, CI = 3.7 to
34.4, P = 0.001) and infected necrosis (OR = 9.4, CI = 6.3 to 13.9,
P = 0.001) were independent predictors of mortality. There was a
significant difference between MOFS of patients who died (mean
= 1.93  1.81) and those who survived (mean = -0.28  0.67),
P < 0.001.
Stratified risk analysis of patients with persistent OF showed
that those with persistent and deteriorating OF (83.3% of total
deaths) had significantly higher mortality as compared with those
with persistent OF alone (16.7% of total deaths). 3/24 (12.5%)
Table 2 Baseline characteristics of all patients on admission
Age (years)a 39.2  13.7
Gender (M/F) 78/36 (68.4/31.6)
Aetiology (alcohol/gallstone/others)
N (%)
57/35/22 (50/30.7/19.3)
APACHE II (24 h)a 8.3  5.9
CRP (mg/l) (48 h)a 142.2  61.5
BMI (kg/m2)a 23.2  1.9
MOFS differencea 0.2  1.3
CTSIa 7.6  2.8
No OF/transient OF/persistent OF, N (%) 37/34/43 (32.5/29.8/37.7)
BMI, Body Mass Index; CRP, C-reactive protein; CTSI, Computerized
Tomography Severity Index; DBA, duration between onset of pain and
admission; MOFS, Modified Organ Failure Score; N, number of patients;
OF, organ failure.
aMean standard deviation.
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patients with POF and 15/19 (78.9%) patients with persistent and
deteriorating OF died, P < 0.001 (Table 5, Figure 1). The risk
estimate for mortality was 26.2 times (CI 5.1–134.9) when per-
sistent OF showed a deteriorating trend in the first week. Thus, a
double hit in the course of SAP with persistent and deteriorating
OF predicts an extremely poor outcome.
Late onset organ failure
Nine patients in the group with no organ failure developed late
onset OF, all of whom had sepsis and three had infected necrosis.
Of the nine patients who developed late onset OF, six required
PCD insertion, four required surgery and three (33.3%) suc-
cumbed to illness.
Discussion
In this study, we found that the patients with POF had higher
APACHE II scores, higherCRP levels, higher radiological indices of
Table 3 Details of organ failure in the 1st week of hospitalization
No organ failure N (%) Transient organ failure N
(%)
Persistent organ failure N
(%)
Renal 45 (39.5) 24 (21) 45 (39.5)
Respiratory 61 (53.5) 15 (13.2) 38 (33.3)
Cardiovascular 88 (77.2) 4 (3.5) 22 (19.3)
Coagulation 92 (80.7) 1 (0.9) 21 (18.4)
Central nervous system 107 (93.9) 0 7 (6.1)
Table 4 Comparison of characteristics of patients with different types of organ failure
No organ failure Transient organ failure Persistent organ failure P-value
N (%) 37 (32.5) 34 (29.8) 43 (37.7)
Age in yearsa 36.7  13.9 38.9  12.8 41.5  14.2 0.30
Gender (male/female) 28/9 25/9 25/18 0.18
Aetiology 0.30
Gall stone 8 11 16
Alcohol 18 8 11
Others 11 5 6
APACHE II (at 24 h)a 3.70  1.4 6.79  3.2 13.65  5.9 <0.001
CRP (at 48 h) (mg/l)a 143.6  68.3 132.7  51.4 148.6  61.5 0.055
BMI (kg/m2)a 22.5  2.1 22.8  1.3 24.3  1.8 <0.001
MOFS differencea 0.03  0.1 0.41  0.6 0.93  1.8 <0.001
Necrosis (Balthazar score)a 2.3  6.5 2.8  7.0 3.8  4.7 <0.001
CTSIa 3.2  1.5 4.6  1.8 8.4  1.7 <0.001
Blood stream infection (N) (%) 6 (16.2) 2 (5.9) 23 (53.5) <0.001
Infected necrosis (N) (%) 3 (8.1) 1 (2.9) 11 (25.6) 0.008
PCD insertion (N) (%) 6 (16.2) 7 (20.6) 20 (46.5) 0.005
Surgery (N) (%) 4 (10.8) 2 (5.9) 13 (30.2) <0.001
Hospitals stay in daysa 10.7  10.6 13.8  10.7 21.5  16.6 0.003
ICU stay in daysa 4.3  3.2 3.2  1.2 12.8  5.7 0.004
Ventilator requirement, (N) (%) 4 (10.8) 0 17 (39.5) <0.001
Mortality (N) (%) 3 (8.1) 0 18 (41.9) <0.001
BMI, Body Mass Index; CRP, C-reactive protein; CTSI, Computerized Tomography Severity Index; DBA, Duration between onset of pain and
admission; MOFS, Modified Organ Failure Score; N, number of patients; OF, organ failure; PCD, percutaneous catheter drainage.
aMean standard deviation.
Table 5 Mortality in different subgroups of patients according to type
of organ failure
Type of organ failure Morality
Early onset transient organ failure 0%
Early onset persistent organ failure 41.9%
Only persistent organ failure 12.5%
Persistent and deteriorating organ failure 78.9%
Late onset organ failure 33%
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severity, more frequent blood stream infection, IN, a requirement
of PCD, surgery and mortality when compared with those with
TOF. Deteriorating organ failure in the first week of hospital stay
conferred a much higher risk of mortality, over and above the risk
associated with POF.
There is increasing evidence thatOF is not an all or none process
as defined in the Atlanta criteria,12 and the time of onset, and
duration and progression of OF influence the outcome. Johnson
et al. studied290patientswithpredictedSAPof which earlyOFwas
present in 174 (60%) patients and OF was persistent in 103
patients.15 Mortality was 35% in the persistent and 1.4% in the
transient OF group. No patients without OF died. Lytras et al.18
studied 234 patients with AP of which 64 patients had predicted
SAP. They identified 33 patients with early onset OF (OF < 5 days
from onset of symptoms). The early onset OF group was subdi-
vided into two groups; TOF group (24 patients,73%) and POF
group (9 patients,33%). There was no mortality in the group
without OF. The mortality was 8.3% in the group with TOF and
77.7% in the group with POF, P < 0.001. Buter et al., in a study of
121 patients with predicted SAP,14 found that the mortality was
(2/68) 3% in patients without organ dysfunction, 0 in patients with
resolving organ dysfunction and (11/20) 55% in patients with
deteriorating organ dysfunction,P = 0.001.They found deteriorat-
ing organ function as an independent predictor of mortality in
concordance with our findings. Buter et al. did not analyse the
duration of OF and its impact on outcome. These studies had
already established the importance of POF in predicting a poor
outcome.However, except for the study by Buter et al. other studies
have not taken into account the dynamicity of OF (overall progres-
sion of OF in the first week of hospitalization for AP). There are no
studies so far that have examined the impact of both POF and
deterioration of OF on mortality in the same cohort of patients.
Sharma et al. described three subgroups of fulminant, subful-
minant and late onset SAP, depending upon the time of onset of
OF. Their study showed that the early onset of OF is associated
with higher mortality.19 The mortality in patients with late onset
OF was 33%, similar to the present observation (30%).
Dynamics of early organ failure
In this study, we looked objectively into the duration of OF, its
severity and the plotted trajectory of OF over the first week of
hospitalization.We calculated the MOFS score on each of the first
7days of hospitalization andcorrelated theoutcomewith change in
theMOFS score (MOFS in day 7minusMOFS in day 1).A positive
MOFS difference thus indicated deterioration in overall severity of
OF. This could be because of multiple organ systems failing and/or
Figure 1 The hazard of mortality in the two groups based on progression of organ failure (Kaplan–Meier curve)
Time of event (days)
No change or improving MOFS (0) 5, 22, 32, 33, 44, 58
Worsening MOFS (1) 2, 2, 3, 3, 4, 7, 10, 11, 12, 15, 16, 17, 18, 19
Dy OF, dynamic change in organ failure.
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progressive worsening of severity of OF.We found that there was a
significant difference between MOFS difference between patients
who succumbed to illness and those who survived. Patients who
haddeterioratingMOFShad significantly highermortality as com-
pared with those who had no change or improvement of MOFS.
Subgroup analysis of mortality in patients with persistent OF
showed that patients with persistent and deteriorating OF as com-
pared with persistent OF alone had significantly higher mortality.
In total, 12.5% patients with persistent OF alone and 78.9%
patients with persistent and deteriorating OF died. The risk esti-
mate formortality is 26.2 times (CI 5.1–134.9) when persistent OF
shows a deteriorating trend in the first week. Thus a double hit in
the early course of SAPwith persistent and deterioratingOF results
in extremely severe acute pancreatitis with a very poor prognosis;
confirming our hypothesis.
The strength of this study lies in the number of patients studied
with SAP and uniformity in the study group as only patients
presenting within 48 h of onset of symptoms were considered. As
compared with previous studies on the duration of OF and dete-
rioration of OF, we looked into the course of disease with respect
to duration of OF, severity and progression. However, the limita-
tion of this study is that we did not calculate MOFS beyond first
week. Continued monitoring of MOFS beyond the first week
could have helped in identifying the onset and course of late onset
OF. Further multicentre studies involving larger numbers of
patients are required to validate our findings. At present the infor-
mation helps only in prognostication; however, a multifactorial
scoring system incorporating the time of onset, duration and
dynamic changes in OF in the early phase of acute pancreatitis can
be developed. Future studies should evaluate the therapeutic
advantage of prioritizing patients with persistent and deteriorat-
ing OF for intensive care.
In conclusion,our study clearly shows thatOF in thefirstweekof
SAP is a dynamic process.Monitoring of the dynamics of disease in
the first week of SAP with modified organ failure score (MOFS)
helps in identifying patients who are likely to have a complicated
course andwe recommendmonitoringMOFS inpatientswith SAP.
The patients with persistent OF have a poor overall outcome and
the mortality is highest in the subgroup of patients with persistent
OF that is deteriorating in the first week of disease. This sub group
of patients requires more aggressive management.
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